Table 2.
The effect of hawthorn extract treatment on selected coagulating and anticoagulants factors of Sprague Dawley rats.
| Groups | Control | Hawthorn-100mg | Hawthorn-200mg | Hawthorn-500mg | P-Value |
|---|---|---|---|---|---|
| Serum SPECAM-1 | 1.111 ± 0.044 | 0.792 ± 0.053 | 0.847 ± 0.092 | 0.873 ± 0.129 | 0.0599 |
| Antithrombin III (Heart) | 34.29 ± 1.11 | 141.6 ± 20.87∗ | 55.12 ± 7.96# | 58.12 ± 8.21# | <0.0001 |
| Heart Factor X | 0.205 ± 0.010 | 0.387 ± 0.120 | 0.165 ± 0.049 | 0.102 ± 0.031# | 0.0529 |
| Antithrombin III (Liver) | 12.98 ± 1.497 | 15.45 ± 1.940 | 11.78 ± 0.979 | 11.11 ± 1.091 | 0.1551 |
| Liver Factor X | 2.893 ± 0.136 | 1.671 ± 0.123∗ | 2.089 ± 0.106∗ | 1.314 ± 0.119∗ | <0.0001 |
∗
indicates significant difference from control.
#
indicates significant difference from Hawthorn-100mg.